Trials / Completed
CompletedNCT04757142
PLASMA Chile (PLASMA Chile)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 246 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multicenter, observational cohort study to collect data on Chilean patients diagnosed with Heart Failure with reduced ejection fraction, their treatments, and their progress in a real-world environment. Additional objectives will be analyzed, such as mortality, and the barriers, if any, to receiving the indicated treatment.
Detailed description
Identify the main epidemiological and clinical characteristics of patients with Heart Failure with reduced ejection fraction, as well as the medical treatment models used.
Conditions
Timeline
- Start date
- 2021-03-11
- Primary completion
- 2024-04-26
- Completion
- 2024-11-12
- First posted
- 2021-02-17
- Last updated
- 2024-12-31
Locations
6 sites across 1 country: Chile
Source: ClinicalTrials.gov record NCT04757142. Inclusion in this directory is not an endorsement.